Chennai’s Iswarya Fertility Center Secures $37 Million to Expand Pan-India IVF Network

Iswarya Fertility Center, a Chennai-headquartered fertility care provider, has secured about $37 million, or roughly Rs 350 crore, from global healthcare investment firm OrbiMed Asia. The company already operates more than 85 centres across eight states, and the fresh funding is intended to widen that footprint further.

According to the company, the round is among the largest growth investments recorded in India’s IVF sector. Proceeds will fund new centres in both existing and underserved markets, along with upgrades to clinical infrastructure and investment in digital capabilities across the network.

The company is also using part of the capital to expand its embryology talent pipeline, addressing a skills gap that has become a bottleneck for fertility chains scaling beyond India’s major metros. Managing director Arun Muthuvel said the plan is to ‘deepen our pan-India presence, enter underserved geographies and keep raising the bar on clinical outcomes.’

Veda Corporate Advisors served as financial adviser to Iswarya and its promoters through the deal. The firm’s managing director, VP Rajan, said the transaction ‘drew strong interest from marquee investors,’ reflecting sustained appetite among global healthcare investors for India’s fertility services market.

The deal adds to a run of significant funding activity in India’s healthcare space this year, with reproductive health emerging as one of the categories drawing consistent investor interest.